Sonovum
Sonovum is a German medical technology company developing a non-invasive intracranial pressure assessment device using transmission ultrasound and AI-powered classification algorithms. The company targets neurotrauma and intensive care centers, with CE marking and product launch expected in Q4 2026.
- Company typePrivate
- Founded2011
- HeadquartersLeipzig, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sonovum does
Sonovum is a German medical technology company headquartered in Leipzig that develops a non-invasive intracranial pressure (ICP) assessment device for use in neurotrauma, intensive care, and emergency settings. Founded in 2011 with a strategic refocus toward non-invasive ICP in 2020, the company combines biosignal expertise, transmission ultrasound, and AI-based classification to detect elevated intracranial pressure without surgically placed invasive probes. Its clinical validation program is currently running across 13 German university hospitals, focusing on patients with traumatic brain injury (TBI), and the company is targeting CE marking under the European Medical Device Regulation (MDR) in Q4 2026.
The company's core product is a compact, standalone bedside device that uses transmission ultrasound to capture skull movement and brain compartment dynamics (brain tissue, blood, cerebrospinal fluid), converts these into a brain pulse curve based on time-of-flight signal analysis, and applies a validated in-house AI classifier to produce a binary elevated-versus-normal ICP assessment in real time. The product is supported by a Medical Advisory Board of leading neurosurgeons and neurologists and is designed to integrate into existing clinical workflows without invasive neurosurgical placement, external monitoring platforms, or adaptive bedside AI.
Commercially, Sonovum operates a pre-revenue direct enterprise sales model targeting leading neurotrauma and intensive care centers, with planned geographic expansion into North America and Asia after European market entry. Revenue mechanics are expected to be hardware sales of the device, with potential secondary software/licensing revenue from the validated algorithm. The company is privately held as Sonovum GmbH, led by CEO Bertram König, CFO Manuela Franke, and CMO Prof. Dr. Jens Gempt, and is actively soliciting investor partnerships to fund CE marking and European market introduction.
Sonovum firmographics
Firmographics- Name
- Sonovum
- Legal name
- Sonovum GmbH
- Website
- https://sonovum.de
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sonovum is a German medical technology company developing a non-invasive intracranial pressure assessment device using transmission ultrasound and AI-powered classification algorithms. The company targets neurotrauma and intensive care centers, with CE marking and product launch expected in Q4 2026.
- Ownership category
- akta.pro rank
Sonovum industry classification
Industry- Product category
- Neurocritical Care Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
Keywords
Where Sonovum is headquartered
LocationHeadquarters
- HQ city
- Leipzig
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Sonovum business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of stand-alone non-invasive ICP assessment device to hospitals, clinics, and healthcare providers. The device is designed as a compact, standalone solution for bedside use.
- Software/Algorithm Services: AI-powered classification algorithms providing real-time ICP assessment. Post-launch, the product operates with a fixed, validated algorithm, suggesting potential software licensing or update services.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Sonovum product offering
Product offeringCore offering
Sonovum develops a compact, standalone medical device that performs non-invasive intracranial pressure (ICP) assessment in real time at the bedside using transmission ultrasound combined with a clinically validated AI classifier. The device eliminates the need for invasive neurosurgical probes and is intended for use in hospitals, emergency departments, ICUs, and potentially pre-hospital, sports, and military settings. Commercial launch is planned for Q4 2026 following CE marking under the European Medical Device Regulation (MDR).
Product overview
Sonovum offers a single core product: a non-invasive ICP (intracranial pressure) assessment device. The device is a compact, stand-alone solution that uses transmission ultrasound technology to capture signals and a clinically validated AI-powered algorithm to classify whether intracranial pressure is elevated or normal. It is designed for use directly at the patient's bedside, integrating seamlessly into existing clinical workflows without the need for invasive probes. The product targets hospitals, emergency departments, intensive care units, and eventually pre-hospital settings such as ambulances. Future applications may include sports and military settings.
Differentiator
Problem solved
Functional benefit
Products and services
- Non-invasive ICP Assessment Device A compact, standalone medical device that uses transmission ultrasound and a clinically validated AI-based classifier to provide real-time, non-invasive assessment of whether intracranial pressure (ICP) is elevated or normal, without requiring invasive probes or additional monitoring systems. Designed for bedside use in hospitals, emergency departments, intensive care units, and potentially pre-hospital environments.
Companies that use Sonovum
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
Sonovum technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Sonovum partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and supporting.
- Universitätsklinikum Carl Gustav Carus DresdencoreClinical partner in multicenter clinical study evaluating non-invasive ICP assessment technology in patients with traumatic brain injury (TBI). Study conducted in accordance with European Medical Device Regulation (MDR).
- Universitätsklinikum FrankfurtcoreClinical partner in multicenter clinical study evaluating non-invasive ICP assessment technology in patients with traumatic brain injury (TBI). Study conducted in accordance with European Medical Device Regulation (MDR).
- Uniklinik RWTH AachencoreClinical partner in multicenter clinical study evaluating non-invasive ICP assessment technology in patients with traumatic brain injury (TBI). Study conducted in accordance with European Medical Device Regulation (MDR).
- LMU Klinikum MünchencoreClinical partner in multicenter clinical study evaluating non-invasive ICP assessment technology in patients with traumatic brain injury (TBI). Study conducted in accordance with European Medical Device Regulation (MDR).
- Universitätsklinikum FreiburgcoreClinical partner in multicenter clinical study evaluating non-invasive ICP assessment technology in patients with traumatic brain injury (TBI). Study conducted in accordance with European Medical Device Regulation (MDR).
- Universitätsklinikum HeidelbergcoreClinical partner in multicenter clinical study evaluating non-invasive ICP assessment technology in patients with traumatic brain injury (TBI). Study conducted in accordance with European Medical Device Regulation (MDR).
- Universitätsklinikum ErlangencoreClinical partner in multicenter clinical study evaluating non-invasive ICP assessment technology in patients with traumatic brain injury (TBI). Study conducted in accordance with European Medical Device Regulation (MDR).
- Medical Advisory BoardcoreInternationally recognized experts in neurosurgery, intensive care, and neurology guiding product development based on real clinical needs and evidence-based insight. Includes Bernhard Meyer (Chairman of Dept. of Neurosurgery, TU Munich), Peter Vajkoczy, Karl Schaller, and Andreas Hetzel (Chairman of Dept. of Neurology).
- BIOSAXONYsupportingPartner organization supporting innovation in biotechnology and life sciences sector, visible in company partner ecosystem.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Sonovum competitors and assessment
Company assessmentBroad incumbents
- Masimo Corporation: Established patient monitoring company expanding into cerebral and brain oximetry (e.g., SedLine, O3 regional oximetry) used in neuro-ICU and operating rooms. Comparable as a broader bedside monitoring and patient assessment platform that could either complement or compete with Sonovum's bedside ICP device.
- Medtronic plc: Global medical device leader with established invasive intracranial pressure monitoring systems (e.g., Camino) widely used in neuro-ICU. Represents the entrenched incumbent that Sonovum is positioning to disrupt with a non-invasive alternative, while also being a potential strategic acquirer.
- Integra LifeSciences (Codman Specialty Surgical): Holds the legacy Codman line of invasive ICP monitoring and neurosurgical drainage products, deeply embedded in neurosurgery workflows worldwide. Directly comparable as the incumbent invasive ICP standard of care that Sonovum seeks to replace in non-invasive ICP assessment.
Regional players
- RAUMEDIC AG: German-headquartered manufacturer of high-precision polymer and silicone components including invasive ICP monitoring catheters and neuromonitoring devices. Directly comparable as a German-based ICP device vendor in Sonovum's primary European market and a likely competitor on hospital tender lists.
- Spiegelberg GmbH: German-based manufacturer of invasive intracranial pressure monitors and related neurosurgical devices (e.g., Silverline, Gaeltec-based probes). A direct incumbent competitor serving the same German and European neurotrauma hospitals targeted by Sonovum, with overlapping ICP-monitoring customer relationships.
Direct peers
- Nisonic AS: Norwegian medical device company developing ultrasound-based cerebral monitoring technologies, including non-invasive intracranial pressure assessment tools. Directly comparable to Sonovum on modality (ultrasound) and clinical application (neuro-monitoring and ICP).
- brain4care: Brazilian health-tech company developing a non-invasive intracranial compliance/pressure monitoring sensor that captures the brain's natural pulsation via an extra-cranial sensor. It is the closest direct competitor to Sonovum, targeting the same non-invasive ICP assessment use case with a comparable acoustic/biosignal approach and pursuing neuro-ICU and emergency applications.
Emerging players
- NovaSignal Corporation: US-based company developing transcranial Doppler (TCD) ultrasound systems for real-time, non-invasive assessment of cerebral blood flow. Comparable to Sonovum as a non-invasive, ultrasound-based neuro-monitoring technology targeting neuro-ICU and emergency settings, though focused on blood flow rather than ICP.
- Infrascan, Inc. US-based company with a near-infrared spectroscopy (NIRS) device (Infrascanner) for non-invasive detection of intracranial hematomas in trauma settings. Comparable to Sonovum as a non-invasive brain assessment tool for TBI triage in emergency and field settings, though using a different modality (NIRS vs. ultrasound).
- Cerebrotech Medical Systems: Neurotechnology company developing non-invasive, portable brain monitoring devices for rapid detection of stroke and brain fluid asymmetries. Comparable to Sonovum as a non-invasive neuro-monitoring device aimed at triage and rapid decision-making in neuro-emergency settings.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Sonovum social profiles
Digital presenceSonovum financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sonovum leadership team
Management profileNumber of profiles
Profiles5 records
Sonovum funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sonovum M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sonovum
What does Sonovum do?
Sonovum develops a compact, standalone medical device that performs non-invasive intracranial pressure (ICP) assessment in real time at the bedside using transmission ultrasound combined with a clinically validated AI classifier. The device eliminates the need for invasive neurosurgical probes and is intended for use in hospitals, emergency departments, ICUs, and potentially pre-hospital, sports, and military settings. Commercial launch is planned for Q4 2026 following CE marking under the European Medical Device Regulation (MDR).
Is Sonovum a public or private company?
Sonovum is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Sonovum founded?
Sonovum was founded in 2011. It employs 11 to 50 people.
Where is Sonovum based?
Sonovum is headquartered in Leipzig, Germany, in the Europe region.
How does Sonovum make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are software/Algorithm Services.
Who are Sonovum's main competitors?
Broad incumbents on record are Masimo Corporation, Medtronic plc and Integra LifeSciences (Codman Specialty Surgical). Regional players are RAUMEDIC AG and Spiegelberg GmbH. Direct peers are Nisonic AS and brain4care. Emerging players are NovaSignal Corporation, Infrascan, Inc. and Cerebrotech Medical Systems.
Does Sonovum have an API?
No public API is recorded for Sonovum.
What industry is Sonovum in?
Sonovum's product category is Neurocritical Care Medical Devices. Its primary akta.pro industry code is HLACAFAG, Medical-Grade Device Connectivity & Device Management (MDM), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3845.